Your browser doesn't support javascript.
loading
Development and implementation of procedures for outpatient naloxone prescribing at a large academic medical center.
Zschoche, Juliana H; Nesbit, Suzanne; Murtaza, Umbreen; Sowell, Amanda; Waldfogel, Julie M; Arwood, Nicole; Rush, Jordan; McNamara, LeAnn; Swarthout, Meghan; Nesbit, Todd; Ortmann, Melinda.
Afiliação
  • Zschoche JH; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD jzschoc1@jhmi.edu.
  • Nesbit S; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Murtaza U; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Sowell A; Department of Pharmacy, Palmetto Health Richland Hospital, Columbia, SC.
  • Waldfogel JM; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Arwood N; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Rush J; Department of Pharmacy, University of North Carolina Hospitals, Chapel Hill, NC.
  • McNamara L; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Swarthout M; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Nesbit T; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
  • Ortmann M; Department of Pharmacy, Johns Hopkins Hospital, Baltimore, MD.
Am J Health Syst Pharm ; 75(22): 1812-1820, 2018 Nov 15.
Article em En | MEDLINE | ID: mdl-30076167
ABSTRACT

PURPOSE:

An interprofessional initiative to operationalize outpatient naloxone prescribing at a large academic medical center is described.

SUMMARY:

The initiative was carried out by a work group of clinical pharmacists and pharmacy administrators in collaboration with physicians and nursing staff leaders from multiple practice settings. An opioid overdose risk-assessment guide was developed on the basis of literature review and expert opinion. An institutional policy to guide identification of high-risk patient populations and facilitate naloxone prescribing and dispensing was developed and vetted by multiple expert committees. Patient education materials were created, and patients at high risk for opioid overdose were educated about overdose risk factors and naloxone use by a pharmacist and/or nurse before discharge or, in some cases, by outpatient pharmacists; when feasible, patients' friends, family members, and/or caregivers were included in education sessions. Interventions included distribution of a pamphlet emphasizing the importance of contacting emergency medical services personnel immediately in the event of an overdose, depicting the process for administration of injectable and nasal spray formulations of naloxone, and providing information on other first-response steps. Collaboration with outpatient pharmacies allowed for successful dispensing of naloxone prescriptions.

CONCLUSION:

The implementation of an outpatient naloxone prescribing policy at a large academic medical center created a streamlined approach for the interprofessional healthcare team to use in providing naloxone education and improved naloxone access to patients at high risk for opioid overdose.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Centros Médicos Acadêmicos / Naloxona / Antagonistas de Entorpecentes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prescrições de Medicamentos / Centros Médicos Acadêmicos / Naloxona / Antagonistas de Entorpecentes Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article